홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Piperidine → Glycyl-phenylalanyl-glycine

HRID 39265
인쇄

반응식

HRID 39265 반응식
C1C2C(COC([NH:18][CH2:19][C:20]([NH:22][C@H:23]([C:31]([NH:33][CH2:34][C:35]([OH:37])=[O:36])=[O:32])[CH2:24][C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=3)=[O:21])=O)C3C(=CC=CC=3)C=2C=CC=1.N1CCCCC1>CN(C=O)C>[NH2:18][CH2:19][C:20]([NH:22][C@H:23]([C:31]([NH:33][CH2:34][C:35]([OH:37])=[O:36])=[O:32])[CH2:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1)=[O:21]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 8082PiperidineHCID 15222489N-Fmoc-glycyl-L-phenylalanyl-glycine

생성물 1

HCID 6992441Glycyl-phenylalanyl-glycine

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

Fmoc-protected tripeptide 74 (546 mg, 0.98 mmol) was treated with a 5% v/v solution of piperidine in DMF (5 mL). After stirring for 45 min, the reaction mixture was concentrated to dryness. The crude material was used for the next step without purification.

후처리

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트
concentration
the reaction mixture was concentrated to dryness
  • customThe crude material was used for the next step without purification
  • 출처 및 근거

    ORD 기록
    ord-7e66b13904154ebcbe524b75757fe2f1
    출처 데이터셋
    uspto-grants-2013_09
    DOI
    10.6084/m9.figshare.5104873.v1
    특허 번호
    US08524691B2

    반응 노트